article thumbnail

Fossil fuel CO2 emissions increase again in 2024

Science Daily: Pharmacology News

Global carbon emissions from fossil fuels have reached a record high in 2024, according to new research.

Research 127
article thumbnail

NASA data shows July 22, 2024 was Earth's hottest day on record

Science Daily: Pharmacology News

July 22, 2024, was the hottest day on record, according to a NASA analysis of global daily temperature data. July 21 and 23 of this year also exceeded the previous daily record, set in July 2023. These record-breaking temperatures are part of a long-term warming trend driven by human activities, primarily the emission of greenhouse gases.

132
132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Viral Vectors - Fall 2024

addgene Blog

If the fall colors are inspiring you to paint your cells in equally vivid colors, you'll want to check out the 34 new preps available in the Addgene viral vector repository! This includes the first Addgene prep packaged in the AAV9-X1.1 serotype.

Packaging 118
article thumbnail

10 clinical trials to watch in the second half of 2024

BioPharma Drive: Drug Pricing

Study results are expected for a pair of closely watched obesity drugs, while key tests await for a high-priced AbbVie acquisition and one of 2023’s largest IPOs.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT

article thumbnail

Cell and gene therapy investment, once booming, is now in a slump

BioPharma Drive: Drug Pricing

Far fewer venture funding rounds were closed by cell and gene therapy developers over the first six months of 2024 than in prior years. Experts say there are several factors.

Therapies 142
article thumbnail

Molecules on the Move: April ’23

Drug Hunter

Capacity Bio’s MAS Receptor Agonists with $35M Raised for FIH Clinical Trials MAS modulator from WO2022165189 example 107 New start-up Capacity Bio backed by RA Capital, Insight Partners, and Remiges Ventures with $35 million funding is working on taking first-in-class mitophagy agonists into clinical trials, which are expected to start in 2024.